Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Jazz Pharmaceuticals PLC - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
JAZZ
Nasdaq
2834
https://www.jazzpharma.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Jazz Pharmaceuticals PLC
Jazz Pharmaceuticals First Quarter 2024 Earnings: Misses Expectations
- May 3rd, 2024 10:31 am
Jazz (JAZZ) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
- May 1st, 2024 11:00 pm
Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care Conference
- May 1st, 2024 8:10 pm
Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance
- May 1st, 2024 8:05 pm
Ardelyx (ARDX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
- Apr 25th, 2024 2:02 pm
Jazz Pharmaceuticals to Present Data Across Growing Oncology Pipeline and Portfolio at ASCO 2024
- Apr 24th, 2024 8:05 pm
Jazz Pharmaceuticals (JAZZ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- Apr 24th, 2024 2:01 pm
3 No-Brainer Stocks to Buy With $300 Right Now
- Apr 24th, 2024 9:21 am
A Closer Look At Jazz Pharmaceuticals plc's (NASDAQ:JAZZ) Uninspiring ROE
- Apr 22nd, 2024 1:02 pm
Jazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024
- Apr 17th, 2024 8:15 pm
Jazz Pharmaceuticals to Showcase Expansive Neuroscience Portfolio at American Academy of Neurology Annual Meeting
- Apr 10th, 2024 11:45 am
Pharma Stock Roundup: AZN Voydeya Gets FDA Nod, MRK KRAS Inhibitor Enters Phase III
- Apr 5th, 2024 12:07 pm
Following the Money Trail: Where are Hedge Funds Investing?
- Apr 4th, 2024 1:15 pm
Jazz Pharmaceuticals Completes Zanidatamab Biologics License Application for Previously Treated HER2-Positive Metastatic Biliary Tract Cancer
- Apr 2nd, 2024 11:30 am
Why Is Jazz (JAZZ) Up 1.3% Since Last Earnings Report?
- Mar 29th, 2024 3:30 pm
Cancer and the Combination Approach
- Mar 28th, 2024 2:15 pm
Jazz Pharmaceuticals Celebrates International Women’s Day
- Mar 20th, 2024 2:15 pm
20 States with the Cheapest Weed in America
- Mar 18th, 2024 7:28 pm
30 Biggest Biotechnology Companies in the World
- Mar 17th, 2024 12:50 pm
Exploring How Jazz Pharmaceuticals Honored U.S. Black History Month
- Mar 14th, 2024 4:00 pm
Scroll